![](/img/cover-not-exists.png)
Prostatic chondroitin sulfate is increased in patients with metastatic disease but does not predict survival outcome
Carmela Ricciardelli, Andrew J. Sakko, Jürgen Stahl, Wayne D. Tilley, Villis R. Marshall, David J. HorsfallVolume:
69
Year:
2009
Language:
english
Pages:
9
DOI:
10.1002/pros.20926
File:
PDF, 177 KB
english, 2009